2017
DOI: 10.5935/2526-5393.20170035
|View full text |Cite
|
Sign up to set email alerts
|

Vacina contra a febre amarela: reações adversas e populações de risco

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
13
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(19 citation statements)
references
References 0 publications
0
13
0
Order By: Relevance
“… 1 , 2 , 3 , 4 , 5 , 6 , 7 Patients with hen's egg allergy have restrictions on the use of some vaccines due to the possibility of adverse events after immunization (AEAI) resulting from the presence of hen's egg allergens in the vaccine, generated during the manufacturing process. 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 …”
Section: Introductionmentioning
confidence: 99%
See 4 more Smart Citations
“… 1 , 2 , 3 , 4 , 5 , 6 , 7 Patients with hen's egg allergy have restrictions on the use of some vaccines due to the possibility of adverse events after immunization (AEAI) resulting from the presence of hen's egg allergens in the vaccine, generated during the manufacturing process. 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 …”
Section: Introductionmentioning
confidence: 99%
“…: hen embryo cells). 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 Regarding hen's egg proteins, the maximum allowed and accepted concentration at 2μg/mL is established as safe for patients with a previous history of anaphylaxis to hen's egg. 8 …”
Section: Introductionmentioning
confidence: 99%
See 3 more Smart Citations